Artificial intelligence in the pharmaceutical industry

Published: 10-Mar-2022 Featured companies: Stevanato Group
Digital

How can AI contribute to a positive return on investment for your inspection equipment?

Download the white paper and discover the benefits

The application of AI in the pharmaceutical industry has already started, make sure you keep up to date with the latest trends.

Read the white paper and discover the benefits of AI applied to the visual inspection process:

You may also like

Research & Development

Neurolentech partners with Kaerus Bioscience to advance neurodevelopmental disorder research

Read more
Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes

Trending Articles

  1. Neurolentech partners with Kaerus Bioscience to advance neurodevelopmental disorder research Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes
  2. Cresset creates new Vice President role to lead its AI strategy Dr Mutlu Dogruel joins from Microsoft, where he was responsible for empowering organisations to implement scalable AI solutions into their workflow
  3. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  4. Autoscribe Informatics Autoscribe Informatics offers <a href='http://www.autoscribeinformatics.com/lims-laboratory-information-management-system'>Laboratory Information Management Systems (LIMS)</a> that are configured to match user requirements and can easily adapt as needs evolve.
  5. AI in pharma: enhancing the drug development process AI and advanced analytics can help to enhance R&D productivity, speed of drug commercialisation and provide access to quality data

Relevant companies

See more

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Research & Development

Neurolentech partners with Kaerus Bioscience to advance neurodevelopmental disorder research

Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes
Analysis

IMPACT CKD model reveals the escalating toll of chronic kidney disease

The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Analysis

Landmark installation for the Vapourtec E-Series system

The landmark spreads the use of E-Series to 20 nations and comes in four standard configurations: easy-Scholar, easy-Polymer, easy-Medchem and easy-Photochem
Digital

Qinecsa Solutions acquires Insife to expand its pharmacovigilance technology solutions

The HALOPV platform developed by Insife is considered a safety database with multivigilance capabilities and more, as it covers the end-to-end management of PV processes
Digital

Real-time data insights powered by digital transformation

The most trailblazing contract development and manufacturing organisations (CDMOs) are at the forefront of digital transformation, leveraging it to offer unparalleled customer service through operational streamlining and the provision of insights
Manufacturing

The future of industrial automation in chemicals

The chemical industry is a large and diverse sector that manufactures a wide range of products, including fibres, plastics, surface finishes and pharmaceutical excipients. Agriculture, construction, transportation, healthcare and consumer goods are just a few sectors that use such chemical products
Research & Development

SimBioSys and General Inception partner to accelerate cancer drug development

PhenoScope, SimBioSys' proprietary digital technology, can cut drug development time and costs significantly
Subscribe now